Bioextrax AB

Bioextrax AB

Bioextrax AB

Overview
Date Founded

2014

Headquarters

Ideongatan 3A, Lund, 223 62, SWE

Type of Company

Public

Employees (Worldwide)

1 - 10

Industries

Biotechnology
IT Consulting & Services

Company Description

Bioextrax AB engages in the development and commercialization of bio-extraction platform technology. It develops, tests, and verifies a potent microbial strain that can extract a variety of pure polyhydroxyalkanoates (PHA) bio-plastic granules from different PHA producing bacteria. Its technology is based on the selective lysis of microbial cell walls under mild conditions using a novel proprietary microbial isolate. The company was founded by Mohammad Hamed Ahmad Ibrahim and Rajni Hatti-Kaul on February 6, 2014 and is headquartered in Lund, Sweden.

Executives & Employees
Paths to Bioextrax AB
Potential Connections via
Relationship Science
You
Bioextrax AB
Recent Transactions
Details Hidden

Bioextrax AB issued SEK Ordinary Shares

Transaction Advisors
Auditor

Advised onBioextrax AB issued SEK Ordinary Shares

Key Stats and Financials As of 2020
Market Capitalization
$60.2M
Total Enterprise Value
$26.1M
Earnings Per Share
$-0.05
EBITDAMargin
-25.6K%
Debt TEV
0x
TEVNet Income
-43.92x
Enterprise Value / Sales
11.2Kx
Revenue
$2,300
Net Profit
$-595K
EBITDA
$-595K
Total Equity
$177K
Total Debt
$0
Investors
Details Hidden

Head-Department of Biotechnology at Lund University

Details Hidden

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bioextrax AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bioextrax AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Bioextrax AB.